Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;13(5):e12618.
doi: 10.1111/cob.12618. Epub 2023 Aug 15.

Long-term impact of gastropexy on use of acid-reducing medication, second operations for gastroesophageal reflux and subjective reflux symptoms after sleeve gastrectomy

Affiliations

Long-term impact of gastropexy on use of acid-reducing medication, second operations for gastroesophageal reflux and subjective reflux symptoms after sleeve gastrectomy

Tone Nygaard Flølo et al. Clin Obes. 2023 Oct.

Abstract

We investigated whether adding gastropexy to sleeve gastrectomy (SG) reduced gastroesophageal reflux disease (GERD) in patients operated for severe obesity, assessed mainly by use of anti-reflux medication (ARM) and second operations due to GERD worsening. In a prospective non-randomized study, patients undergoing SG at two Norwegian hospitals were included from 2011 to 2015 and followed for 7 years. GERD was defined by regular use of ARM, and epigastric pain and heartburn were measured by the Rome II questionnaire. Gastropexy was done by suturing the gastrocolic ligament to the staple line. Patients undergoing SG only, mainly before gastropexia was introduced in 2013, were compared to those with additional gastropexy from 2013 onwards. Of 376 included patients (75% females, mean age 42.6 years and BMI 42.9 kg/m2 ), 350 (93%) and 232 (62%) were available for evaluation after 1 and 7 years, respectively. Baseline characteristics in the no-gastropexy (n = 235) and gastropexy groups (n = 141) were similar. In patients without ARM use before surgery, the use increased and in those that used ARM at baseline, the proportion decreased, with no difference in the no-gastropexy and gastropexy groups. With a combined endpoint of ARM use and/or second operation for GERD, there was no difference during follow-up between the two groups. With time, adding gastropexy did not reduce symptoms of GERD significantly. In this population, adding gastropexy to SG did not reduce use of ARM and/or second operation for uncontrolled GERD, epigastric pain or heartburn during the first 7 postoperative years.

Keywords: Sleeve gastrectomy; gastroesophageal reflux disease; gastropexy.

PubMed Disclaimer

References

REFERENCES

    1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900-1920. quiz 1943.
    1. Bolckmans R, Roriz-Silva R, Mazzini GS, Altieri MS, Docimo S, Campos GM. Long-term implications of GERD after sleeve gastrectomy. Curr Surg Rep. 2021;9(3):7.
    1. Soong TC, Almalki OM, Lee WJ, et al. Revision of sleeve gastrectomy with hiatal repair with Gastropexy for Gastroesophageal Reflux Disease. Obes Surg. 2019;29(8):2381-2386.
    1. Sabry K, Elmaleh HM, El-Swaify ST, et al. Surgical management algorithm for intrathoracic sleeve migration: a retrospective series and literature review. J Laparoendosc Adv Surg Tech A. 2022;32(10):1078-1091.
    1. Fouad MMB, Ibraheim SMN, Ibraheim P, Maurice KK, Saber AT. Assessment of the role of omentopexy in laparoscopic sleeve gastrectomy: a tertiary center experience. J Laparoendosc Adv Surg Tech A. 2022;32(9):962-968.

LinkOut - more resources